Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Disease area: Airway diseases, Paediatric lung diseases

Abstract

Rationale: Patients who were clinically highly suspected asthma occasionally showed negative results in methacholine challenge test (MCT), but showed higher bronchodilator responsiveness (BDR) after methacholine induced bronchoconstriction. The aim of this study was to assess the usefulness of BDR following methacholine-induced bronchoconstriction as a tool for the therapeutic plan in clinically suspected asthmatic patients with negative results in MCT. Methods: MCT was performed in 530 children for evaluation of asthma. Immediately after MCT, patients were asked to inhale short-acting beta2 agonists to evaluate BDR. BDR was measured as the percent increase in FEV1 after treatment. Total serum IgE levels, total eosinophil counts, and specific IgE levels were measured in most children. Schedule visits at 1-month to 6-month intervals were done for 3months to 4 years. Results: Among 530 children, 219 patients showed negative results (PC₂₀ >25mg/mL) in MCT. Out of children with negative MCT, 37 patients expressed over 12% increase (high BDR) and 182 patients expressed under 12% increase (low BDR) in FEV1 after bronchodilator following methacholine induced bronchoconstriction. Among patients with high BDR and negative MCT, 37.8% patients were required inhaled corticosteroid therapy for control of their symptoms. But, among patients with low BDR and negative MCT, only 10.8% patients were required inhaled corticosteroid. Conclusion: In clinically highly suspected asthmatic children with negative MCT, BDR following methacholine-induced bronchoconstriction seems to play a considerable role for the decision of treatment with inhaled corticosteroid.

Rating:

Share or cite this content

Citations should be made in the following way:
T.W. Song (Goyang, Republic Of Korea). Bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with clinically highly suspected asthma. Eur Respir J 2012; 40: Suppl. 56, 1946

Member's Comments

No comment yet.

Related content which might interest you: Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations Source: Eur Respir J 2016; 48: 104-114 Year: 2016 Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004 Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011 Over time effect of montelukast in asthmatic children with exercise-induced bronchoconstriction Source: Eur Respir J 2005; 26: Suppl. 49, 162s Year: 2005 Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma Year: 2006 Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009 Predictors of methacholine responsiveness in a population of patients with suspected bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 295s Year: 2003 Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001 Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002 Bronchial hyperresponsiveness to methacholine and exercise, relation to allergy in asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 504s Year: 2002 Cough during airway challenges: associations with bronchoconstriction and asthma Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Cholinergic tone and airway hyperresponsiveness in patients with persistent allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 Exercise induced bronchoconstriction and dyspnoea in asthmatic children Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood Year: 2011 eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Dyspnoea perception and reversibility of methacholine-induced bronchoconstriction in asthmatics with unlimited airway narrowing Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005 The role of specific airways resistance and spirometry in assessing bronchodilator responsiveness in preschool children with and without asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010